Alaunos Therapeutics Inc (TCRT)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
2,769,100
EV to revenue ratio (TTM)
957.92
EV to ebitda
-3.545
Financial Performance
Revenue (TTM)
3,000
Gross profit (TTM)
-1,643,000
EBITDA
-4,034,000
Profitability
Operating margin (TTM)
-135,233.00%
Profit margin
0.00%
Return on assets (TTM)
-81.10%
Return on equity (TTM)
-185.90%
Per Share Metrics
Revenue per share (TTM)
0
EPS
-1.75
Diluted EPS (TTM)
-1.75
Book value
0.26
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
18.48
PEG ratio
0.584
Price to sales ratio (TTM)
923.04
Price to book ratio (TTM)
4.598
Growth
Quarterly earnings growth (YoY)
-25.00%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
Buy
Hold
Sell
Strong sell
Risk & Volatility
Beta
-0.968